Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Assessing Predictive Value of 18 F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose (FDG) Positron Emission Tomography During Radio-chemotherapy for Locally Advanced Epidermoid Carcinoma of Head and Neck

NCT02469922 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT02469922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02469922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Assessing Predictive Value of 18 F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose (FDG) Positron Emission Tomography During Radio-chemotherapy for Locally Advanced Epidermoid Carcinoma of Head and Neck
Lead sponsor
Center Eugene Marquis
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
January 29, 2021
Enrollment
130 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced malignant neoplasm, malignant neoplasm of head and neck